Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities

Korn, 2017, Myeloid malignancies and the microenvironment, Blood, 129, 811, 10.1182/blood-2016-09-670224 Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544 Tallman, 2019, Ocn, Hammond L, Ogba N: acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 17, 721, 10.6004/jnccn.2019.0028 Shallis, 2019, Epidemiology of acute myeloid leukemia: recent progress and enduring challenges, Blood Rev, 36, 70, 10.1016/j.blre.2019.04.005 Cortes, 2021, Determination of fitness and therapeutic options in older patients with acute myeloid leukemia, Am J Hematol, 96, 493, 10.1002/ajh.26079 DeWolf, 2020, How I treat relapsed or refractory AML, Blood, 136, 1023, 10.1182/blood.2019001982 Sekeres, 2020, American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults, Blood Adv, 4, 3528, 10.1182/bloodadvances.2020001920 Ganzel, 2016, Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer research group trials, 1980-2008, J Clin Oncol, 34, 3544, 10.1200/JCO.2016.67.5892 Lee, 2021, Treatment outcomes of intracranial myeloid sarcomas: a Meta-analysis, World Neurosurg, 148, 29, 10.1016/j.wneu.2021.01.004 Mau, 2019, Neuroleukemiosis: Diagnosis and management, Clin Neurol Neurosurg, 184, 10.1016/j.clineuro.2019.04.019 Alakel, 2017, Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia, Cancer Manag Res, 9, 97, 10.2147/CMAR.S125259 Cheng, 2015, Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults, BMC Cancer, 15, 344, 10.1186/s12885-015-1376-9 Rozovski, 2015, Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia, Leuk Lymphoma, 56, 1392, 10.3109/10428194.2014.953148 Shihadeh, 2012, Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease, Cancer, 118, 112, 10.1002/cncr.26253 Prem, 2019, Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment, Eur J Haematol, 103, 483, 10.1111/ejh.13314 Del Principe, 2018, Involvement of central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome, Semin Hematol, 55, 209, 10.1053/j.seminhematol.2018.02.006 Bar, 2015, Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation, Biol Blood Marrow Transplant, 21, 546, 10.1016/j.bbmt.2014.11.683 Ikegawa, 2017, Central nervous system involvement at the time of allogeneic hematopoietic stem cell transplantation is associated with a poor outcome in patients with acute myeloid leukemia, Pathol Oncol Res, 23, 433, 10.1007/s12253-016-0162-6 Mayadev, 2011, Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement, Int J Radiat Oncol Biol Phys, 80, 193, 10.1016/j.ijrobp.2010.01.062 Jabbour, 2017, Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia, Am J Hematol, 92, 924, 10.1002/ajh.24799 Peterson, 1987, Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission, Am J Med, 83, 464, 10.1016/0002-9343(87)90756-X Deak, 2021, A narrative review of central nervous system involvement in acute leukemias, Ann Transl Med, 9, 68, 10.21037/atm-20-3140 Bergstrom, 2021, The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement, Leuk Res, 100, 10.1016/j.leukres.2020.106480 Johnston, 2017, Central nervous system disease in pediatric acute myeloid leukemia: a report from the Children’s oncology group, Pediatr Blood Cancer, 64, 10.1002/pbc.26612 Holmes, 1985, A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22), Blood, 65, 1071, 10.1182/blood.V65.5.1071.1071 Leite da Silveira, 2015, Nizam Pfeilsticker L: bilateral peripheral facial palsy and mastoid infiltration as symptoms of relapsed acute myeloid leukemia, Eur Ann Otorhinolaryngol Head Neck Dis, 132, 41, 10.1016/j.anorl.2013.09.003 Sanz, 2009, Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet, Blood, 113, 1875, 10.1182/blood-2008-04-150250 Shen, 2020, Zhou, Li L, ye X, Xie W: the diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patients, Hematology, 25, 258, 10.1080/16078454.2020.1781500 Le Rhun, 2013, Carcinomatous meningitis: Leptomeningeal metastases in solid tumors, Surg Neurol Int, 4, S265, 10.4103/2152-7806.111304 Molander, 2015, Cerebrospinal fluid (CSF) directed antineoplastic agents: a review of current knowledge, J Cancer Prev Curr Res, 2, 00026 Walker, 2014, Comprehensive craniospinal radiation for controlling central nervous system leukemia, Int J Radiat Oncol Biol Phys, 90, 1119, 10.1016/j.ijrobp.2014.08.004 Chen, 2021, Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia, Ann Hematol, 100, 505, 10.1007/s00277-020-04380-0 Oshima, 2008, Kanto study Group for Cell T: central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 14, 1100, 10.1016/j.bbmt.2008.07.002 Zheng, 2014, Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia, Hematology, 19, 208, 10.1179/1607845413Y.0000000117 Pileri, 2007, Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients, Leukemia, 21, 340, 10.1038/sj.leu.2404491 Neiman, 1981, Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases, Cancer, 48, 1426, 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G Cervantes, 2015, Intracranial CNS manifestations of myeloid sarcoma in patients with acute myeloid leukemia: review of the literature and three case reports from the Author’s institution, J Clin Med, 4, 1102, 10.3390/jcm4051102 Slouma, 2020, Epidural myeloid sarcoma as the presenting symptom of chronic myeloid leukemia blast crisis, Clin Rheumatol, 39, 2453, 10.1007/s10067-020-05167-4 Cribe, 2013, Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET, Eur J Haematol, 90, 273, 10.1111/ejh.12085 Avni, 2011, Myeloid sarcoma: current approach and therapeutic options, Ther Adv Hematol, 2, 309, 10.1177/2040620711410774 Yang, 2017, Clinicoradiological characteristics, management and prognosis of primary myeloid sarcoma of the central nervous system: a report of four cases, Oncol Lett, 14, 3825, 10.3892/ol.2017.6620 Capek, 2015, Tumefactive appearance of peripheral nerve involvement in hematologic malignancies: a new imaging association, Skeletal Radiol, 44, 1001, 10.1007/s00256-015-2151-3 Ubogu, 2020, Biology of the human blood-nerve barrier in health and disease, Exp Neurol, 328, 10.1016/j.expneurol.2020.113272 Kiyoki, 2020, (18)FDG-PET imaging and histopathology in neuroleukemiosis with acute myeloid leukemia, Int J Hematol, 112, 433, 10.1007/s12185-020-02976-w Devine, 2021, Paraneoplastic neurological syndromes: clinical presentations and management, Ther Adv Neurol Disord, 14, 10.1177/1756286420985323 Rollig, 2015, How I treat hyperleukocytosis in acute myeloid leukemia, Blood, 125, 3246, 10.1182/blood-2014-10-551507 Ganzel, 2012, Hyperleukocytosis, leukostasis and leukapheresis: practice management, Blood Rev, 26, 117, 10.1016/j.blre.2012.01.003 Porcu, 1997, Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate, Br J Haematol, 98, 433, 10.1046/j.1365-2141.1997.1943011.x Ruggiero, 2016, Management of Hyperleukocytosis, Curr Treat Options Oncol, 17, 7, 10.1007/s11864-015-0387-8 Oberoi, 2014, Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis, Leuk Res, 38, 460, 10.1016/j.leukres.2014.01.004 Bewersdorf, 2020, Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-a systematic review and meta-analysis, Transfusion, 60, 2360, 10.1111/trf.15994 Chen, 2012, Intracranial hemorrhage in adult patients with hematological malignancies, BMC Med, 10, 97, 10.1186/1741-7015-10-97 Chen, 2009, Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia, Ann Oncol, 20, 1100, 10.1093/annonc/mdn755 David, 2018, Mechanisms and management of coagulopathy in acute promyelocytic leukemia, Thromb Res, 164, S82, 10.1016/j.thromres.2018.01.041 Naymagon, 2019, Predictors of early hemorrhage in acute promyelocytic leukemia, Leuk Lymphoma, 60, 2394, 10.1080/10428194.2019.1581187 Sanz, 2020, Advances in the management of coagulopathy in acute promyelocytic leukemia, Thromb Res, 191, S63, 10.1016/S0049-3848(20)30399-6 Kwaan, 2010, Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia, Semin Thromb Hemost, 36, 917, 10.1055/s-0030-1267045 Kwaan, 2019, The role of abnormal hemostasis and fibrinolysis in morbidity and mortality of acute Promyelocytic leukemia, Semin Thromb Hemost, 45, 612, 10.1055/s-0039-1693478 Cao, 2017, Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia, Blood, 129, 1855, 10.1182/blood-2016-09-739334 Mantha, 2017, Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era, Blood, 129, 1763, 10.1182/blood-2016-10-747170 Sanz, 2019, Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet, Blood, 133, 1630, 10.1182/blood-2019-01-894980 Mitrovic, 2015, Thrombotic events in acute promyelocytic leukemia, Thromb Res, 135, 588, 10.1016/j.thromres.2014.11.026 Dietrich, 2020, 26, 1646 Ouyang, 2021, Imaging of neurologic injury following oncologic therapy, Radiol Clin North Am, 59, 425, 10.1016/j.rcl.2021.01.008 Dowling, 2018, Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact, Bone Marrow Transplant, 53, 199, 10.1038/bmt.2017.239 Siegal, 2007, Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance, Biol Blood Marrow Transplant, 13, 1369, 10.1016/j.bbmt.2007.07.013 Dulamea, 2018, Neurological complications of hematopoietic cell transplantation in children and adults, Neural Regen Res, 13, 945, 10.4103/1673-5374.233431 Maffini, 2017, Neurologic complications after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 23, 388, 10.1016/j.bbmt.2016.12.632 Gavriilaki, 2019, Neurologic complications after allogeneic transplantation: a meta-analysis, Ann Clin Transl Neurol, 6, 2037, 10.1002/acn3.50909 Balaguer-Rosello, 2019, Noninfectious neurologic complications after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 25, 1818, 10.1016/j.bbmt.2019.05.024 Ke, 2019, Central nervous system complications after allogeneic hematopoietic stem cell transplantation in children, Acta Haematol, 142, 217, 10.1159/000499651 Kantarjian, 2021, Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach, Cancer, 127, 1186, 10.1002/cncr.33477 Coombs, 2016, Pseudotumor Cerebri in acute Promyelocytic leukemia patients on intergroup protocol 0129: clinical description and recommendations for new diagnostic criteria, Clin Lymphoma Myeloma Leuk, 16, 146, 10.1016/j.clml.2015.11.018 Holmes, 2012, All-trans retinoic acid-induced Pseudotumor Cerebri during induction therapy for acute Promyelocytic leukemia: a case report and literature review, Case Rep Oncol Med, 2012